Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2
Conditions: Metastatic Cancer; Prostate CancerInterventions: Drug: docetaxel; Genetic: RNA analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: circulating tumor cell analysis; Other: laboratory biomarker analysisSponsor: ICORG- All Ireland Cooperative Oncology Research GroupRecruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Docetaxel | Genetics | Hormone Refractory Prostate Cancer | Research | Taxotere